litlas
ログインアカウント作成

Hideki Fujii

1986–2026 年に発表

185
論文数
22,213
被引用数
91
h 指数
166
i10 指数

被引用数

Hideki Fujii の年別被引用数1977 年: 被引用 1 件1989 年: 被引用 1 件1992 年: 被引用 6 件1993 年: 被引用 3 件1994 年: 被引用 1 件1995 年: 被引用 7 件1996 年: 被引用 10 件1997 年: 被引用 3 件1998 年: 被引用 8 件1999 年: 被引用 6 件2000 年: 被引用 30 件2001 年: 被引用 31 件2002 年: 被引用 45 件2003 年: 被引用 75 件2004 年: 被引用 74 件2005 年: 被引用 79 件2006 年: 被引用 90 件2007 年: 被引用 126 件2008 年: 被引用 124 件2009 年: 被引用 157 件2010 年: 被引用 196 件2011 年: 被引用 192 件2012 年: 被引用 263 件2013 年: 被引用 280 件2014 年: 被引用 277 件2015 年: 被引用 290 件2016 年: 被引用 233 件2017 年: 被引用 209 件2018 年: 被引用 178 件2019 年: 被引用 670 件2020 年: 被引用 786 件2021 年: 被引用 757 件2022 年: 被引用 649 件2023 年: 被引用 454 件2024 年: 被引用 767 件2025 年: 被引用 376 件2026 年: 被引用 10 件1978〜1988 年は被引用が無いため表示していません1990〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,344 件、この内訳の 22.5%中国: 引用元論文 1,427 件、この内訳の 13.7%日本: 引用元論文 1,151 件、この内訳の 11.1%ドイツ: 引用元論文 501 件、この内訳の 4.8%イギリス: 引用元論文 496 件、この内訳の 4.8%イタリア: 引用元論文 430 件、この内訳の 4.1%フランス: 引用元論文 380 件、この内訳の 3.6%韓国: 引用元論文 287 件、この内訳の 2.8%カナダ: 引用元論文 262 件、この内訳の 2.5%オーストラリア: 引用元論文 228 件、この内訳の 2.2%スペイン: 引用元論文 190 件、この内訳の 1.8%オランダ: 引用元論文 189 件、この内訳の 1.8%
0%22.5%その他 24.3%

機関

分野

  • Medicine61.3%
  • Immunology and Microbiology21.2%
  • Biochemistry, Genetics and Molecular Biology13.3%
  • Neuroscience0.7%
  • Engineering0.7%
  • Dentistry0.5%
  • その他2.3%

トピック

  • Liver Disease Diagnosis and Treatment7.7%
  • Immune Cell Function and Interaction5.3%
  • IL-33, ST2, and ILC Pathways3.7%
  • Immunotherapy and Immune Responses3%
  • Cancer Immunotherapy and Biomarkers2.5%
  • Eosinophilic Esophagitis2.3%
  • その他75.5%

共著者

全論文

検索で開く
  1. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

    著者: Jie Li, Biyao Zou, Yee Hui Yeo, Yuemin Feng, Xiaoyu Xie, Dong Hyun Lee, Hideki Fujii, Yuankai Wu, Leslie Y. Kam, Fanpu Ji, Xiaohe Li, Nicholas Chien, Mike Wei, Eiichi Ogawa, Changqing Zhao, Xia Wu, Christopher D Stave, Linda Henry, Scott D. Barnett, Hirokazu Takahashi, Norihiro Furusyo, Yuichiro Eguchi, Yao‐Chun Hsu, Teng‐Yu Lee, Wanhua Ren, Chengyong Qin, Dae Won Jun, Hidenori Toyoda, Vincent Wai‐Sun Wong, Ramsey Cheung, Qiang Zhu, Mindie H. Nguyen - ˜The œLancet. Gastroenterology & hepatology 2019 被引用: 1,051

  2. The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease

    著者: Hideki Fujii, Norifumi Kawada, Japan Study Group of NAFLD (JSG-NAFLD) - International Journal of Molecular Sciences 2020 被引用: 299

  3. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells

    著者: Kazuyo Moro, Taketo Yamada, M. Tanabe, Tsutomu Takeuchi, Tomokatsu Ikawa, Hiroshi Kawamoto, Jun-ichi Furusawa, Masashi Ohtani, Hideki Fujii, Shigeo Koyasu - Nature 2009 被引用: 1,984

  4. Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD

    著者: Hirokazu Takahashi, Takaomi Kessoku, Miwa Kawanaka, Michihiro Nonaka, Hideyuki Hyogo, Hideki Fujii, Tomoaki Nakajima, Kento Imajo, Kenichi Tanaka, Yoshihito Kubotsu, Hiroshi Isoda, Satoshi Oeda, Osamu Kurai, Masato Yoneda, Masafumi Ono, Yoichiro Kitajima, Ryo Tajiri, Ayako Takamori, Atsushi Kawaguchi, Shinichi Aishima, Masayoshi Kage, Atsushi Nakajima, Yuichiro Eguchi, Keizo Anzai - Hepatology Communications 2021 被引用: 149

  5. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer

    著者: Yoshiki Mizukami, Koji Kono, Yoshihiko Kawaguchi, Hidenori Akaike, Kazuyasu Kamimura, Hidemitsu Sugai, Hideki Fujii - International Journal of Cancer 2008 被引用: 374

  6. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

    著者: Yoshio Sumida, Masato Yoneda, Hideyuki Hyogo, Yoshito Itoh, Masafumi Ono, Hideki Fujii, Yuichiro Eguchi, Yasuaki Suzuki, Noriaki Aoki, Kazuyuki Kanemasa, Koji Fujita, Kazuaki Chayama, Toshiji Saibara, Norifumi Kawada, Kazuma Fujimoto, Yutaka Kohgo, Toshikazu Yoshikawa, Takeshi Okanoue, Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD) - BMC Gastroenterology 2012 被引用: 385

  7. Porphyromonas gingivalis Outer Membrane Vesicles Stimulate Gingival Epithelial Cells to Induce Pro-Inflammatory Cytokines via the MAPK and STING Pathways

    著者: Yuta Uemura, Yuka Hiroshima, Ayano Tada, Keiji Murakami, Kaya Yoshida, Yuji Inagaki, Tomomi Kuwahara, Akikazu Murakami, Hideki Fujii, Hiromichi Yumoto - Biomedicines 2022 被引用: 48

  8. The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study

    著者: for the Japan Study Group of Non-Alcoholic Fatty Liver Disease (JSG-NAFLD), Hiroshi Ishiba, Yoshio Sumida, Saiyu Tanaka, Masato Yoneda, Hideyuki Hyogo, Masafumi Ono, Hideki Fujii, Yuichiro Eguchi, Yasuaki Suzuki, Masashi Yoneda, Hirokazu Takahashi, Takashi Nakahara, Yuya Seko, Kojiro Mori, Kazuyuki Kanemasa, Keiji Shimada, Sunsuke Imai, Kento Imajo, Takumi Kawaguchi, Atsushi Nakajima, Kazuaki Chayama, Toshiji Saibara, Toshihide Shima, Kazuma Fujimoto, Takeshi Okanoue, Yoshito Itoh - Journal of Gastroenterology 2018 被引用: 129

  9. Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study

    著者: Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Hidenori Toyoda, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Sakura Yamamura, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Norifumi Kawada, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue - Clinical Gastroenterology and Hepatology 2022 被引用: 106

  10. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice

    著者: Kota Yano, Kanji Yamaguchi, Yuya Seko, Shinya Okishio, Hiroshi Ishiba, Nozomi Tochiki, Aya Takahashi, Seita Kataoka, Keiichiroh Okuda, Yu Liu, Hideki Fujii, Atsushi Umemura, Michihisa Moriguchi, Takeshi Okanoue, Yoshito Itoh - Laboratory Investigation 2021 被引用: 53

  11. Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder

    著者: Masafumi Fukagawa, Keitaro Yokoyama, Fumihiko Koiwa, Masatomo Taniguchi, Tetsuo Shoji, Junichiro James Kazama, Hirotaka Komaba, Ryoichi Ando, Takatoshi Kakuta, Hideki Fujii, Msasaaki Nakayama, Yugo Shibagaki, Seiji Fukumoto, Naohiko Fujii, Motoshi Hattori, Akira Ashida, Kunitoshi Iseki, Takashi Shigematsu, Yusuke Tsukamoto, Yoshiharu Tsubakihara, Tadashi Tomo, Hideki Hirakata, Tadao Akizawa, CKD‐MBD Guideline Working Group, Japanese Society for Dialysis Therapy - Therapeutic Apheresis and Dialysis 2013 被引用: 397

  12. Vitamin D Activates the Nrf2-Keap1 Antioxidant Pathway and Ameliorates Nephropathy in Diabetic Rats

    著者: Kentaro Nakai, Hideki Fujii, Koji Kono, Shunsuke Goto, Riko Kitazawa, Sohei Kitazawa, Michinori Hirata, Masami Shinohara, Masafumi Fukagawa, Shinichi Nishi - American Journal of Hypertension 2013 被引用: 214

  13. The Pathogenic Factors from Oral Streptococci for Systemic Diseases

    著者: Hiromichi Yumoto, Katsuhiko Hirota, Kouji Hirao, Masami Ninomiya, Keiji Murakami, Hideki Fujii, Yoichiro Miyake - International Journal of Molecular Sciences 2019 被引用: 86

  14. Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery

    著者: Hiromichi Kawaida, Hiroshi Kono, Naohiro Hosomura, Hidetake Amemiya, Jun Itakura, Hideki Fujii, Daisuke Ichikawa - World Journal of Gastroenterology 2019 被引用: 184

  15. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction

    著者: Hideki Fujii, Shunsuke Goto, Masafumi Fukagawa - Toxins 2018 被引用: 135

  16. Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice

    著者: Kanji Yamaguchi, Yoshito Itoh, Chihiro Yokomizo, Takeshi Nishimura, Toshihisa Niimi, Hideki Fujii, Takeshi Okanoue, Toshikazu Yoshikawa - Laboratory Investigation 2010 被引用: 130

  17. Optimal Phosphate Control Related to Coronary Artery Calcification in Dialysis Patients

    著者: Yoshitaka Isaka, Takayuki Hamano, Hideki Fujii, Yoshihiro Tsujimoto, Fumihiko Koiwa, Yusuke Sakaguchi, Ryoichi Tanaka, Noriyuki Tomiyama, Fuminari Tatsugami, Satoshi Teramukai - Journal of the American Society of Nephrology 2021 被引用: 91

  18. Anti-fibrotic treatments for chronic liver diseases: The present and the future

    著者: Naoshi Odagiri, Tsutomu Matsubara, Misako Sato, Hideki Fujii, Masaru Enomoto, Norifumi Kawada - Clinical and Molecular Hepatology 2020 被引用: 61

  19. Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease

    著者: Eri Okada, Naoya Morisada, Tomoko Horinouchi, Hideki Fujii, Takayuki Tsuji, Masayoshi Miura, Hideyuki Katori, Masashi Kitagawa, Kunio Morozumi, Takanobu Toriyama, Yuki Nakamura, Ryuta Nishikomori, Sadayuki Nagai, Atsushi Kondo, Yuya Aoto, Shinya Ishiko, Rini Rossanti, Nana Sakakibara, China Nagano, Tomohiko Yamamura, Shingo Ishimori, Joichi Usui, Kunihiro Yamagata, Kazumoto Iijima, Toshiyuki Imasawa, Kandai Nozu - Kidney International Reports 2022 被引用: 30

  20. Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary Cholangitis

    著者: Akira Honda, Atsushi Tanaka, Tetsuji Kaneko, Atsumasa Komori, Masanori Abe, Mie Inao, Tadashi Namisaki, Naoaki Hashimoto, Kazuhito Kawata, Atsushi Takahashi, Masashi Ninomiya, Jong‐Hon Kang, Mie Arakawa, Satoshi Yamagiwa, Satoru Joshita, Takeji Umemura, Ken Sato, Akira Kaneko, Kentaro Kikuchi, Jun Itakura, Takako Nomura, Keisuke Kakisaka, Hideki Fujii, Norifumi Kawada, Yasuhiro Takikawa, Tsutomu Masaki, Hiromasa Ohira, Satoshi Mochida, Hitoshi Yoshiji, Satoshi Iimuro, Yasushi Matsuzaki, Hajime Takikawa, Japan PBC Study Group - Hepatology 2019 被引用: 118

  21. Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma

    著者: Yoshiyuki Suzuki, Kousaku Mimura, Yuya Yoshimoto, Mitsuaki Watanabe, Yu Ohkubo, Shinichirou Izawa, Kazutoshi Murata, Hideki Fujii, Takashi Nakano, Koji Kono - Cancer Research 2012 被引用: 217

  22. Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study

    著者: Hideki Fujii, Haruna Doi, Tetsuhisa Ko, Taito Fukuma, Toru Kadono, Kohei Asaeda, Reo Kobayashi, Takahiro Nakano, Toshifumi Doi, Yoshikazu Nakatsugawa, Shinya Yamada, Takeshi Nishimura, Naoya Tomatsuri, Hideki Sato, Yusuke Okuyama, Hiroyuki Kimura, Etsuko Kishimoto, Nami Nakabe, Takatomo Shima - BMC Gastroenterology 2020 被引用: 60

  23. Role of vitamin E in the treatment of non-alcoholic steatohepatitis

    著者: Yoshio Sumida, Masato Yoneda, Yuya Seko, Hirokazu Takahashi, Nagisa Hara, Hideki Fujii, Yoshito Itoh, Masashi Yoneda, Atsushi Nakajima, Takeshi Okanoue - Free Radical Biology and Medicine 2021 被引用: 37

  24. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients

    著者: Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Takashi Nakahara, Hideyuki Hyogo, Masato Yoneda, Yoshio Sumida, Yuichiro Eguchi, Hideki Fujii, Masafumi Ono, Takumi Kawaguchi, Kento Imajo, Hiroshi Aikata, Saiyu Tanaka, Kazuyuki Kanemasa, Kazuma Fujimoto, Keizo Anzai, Toshiji Saibara, Michio Sata, Atushi Nakajima, Yoshito Itoh, Kazuaki Chayama, Takeshi Okanoue - Journal of Gastroenterology 2013 被引用: 163